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ABSTRACT
Hulslander, Allison, Audiology Doctoral Project, University of South Florida, June,
2003. Incidence of peripheral vestibulopathy in BPPV patients with and without prior
otologic history.
The incidence data provided by previous investigations of peripheral
vestibulopathy in patients with benign paroxysmal positional vertigo (BPPV) are quite
variable. This variability may be explained, in part, by the otologic history of the patients
included in these studies. Specifically, patients with a prior history of other otologic
disease and BPPV should be more likely to present with peripheral vestibulopathy than
patients without no prior history of otologic disease and BPPV. The purpose of this study
was to determine the incidence of peripheral vestibulopathy in these two groups of BPPV
patients. Caloric responses were analyzed for two groups of patients with posterior canal
BPPV, those with a positive history of otologic disease and those with a negative history
of otologic disease. Data were analyzed retrospectively for 157 BPPV patients. Patients
with a positive history of otologic disease exhibited a greater incidence of peripheral
vestibulopathy than the negative history group. The positive history group, on average,
also exhibited a larger unilateral weakness than those patients in the negative history
group. We conclude that patients with BPPV and a prior history of otologic disease are
more likely to present with peripheral vestibulopathy than patients with BPPV and no
history of otologic disease
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INTRODUCTION
According to the National Institutes of Health, complaints of dizziness and vertigo
account for nearly 7 million physician visits a year (National Institute on Deafness and
other Communication Disorders, 1995). Vestibular disorders account for approximately
85% of these visits (National Institute of Neurological and Communicative Disorders and
Stroke, 1986). Vestibular disorders are typically characterized by vertigo, which is
described as a perception of motion even though the patient may not be moving. Patients
with vertigo often perceive they are spinning or that the environment is spinning around
them.
The pathologies underlying vertigo may be divided into two broad categories:
pathologies of peripheral etiology and pathologies of central etiology. Many diseases
may affect the peripheral vestibular system, including Meniere’s disease, vestibular
neuritis/labyrinthine ischemia, acoustic neuroma/vestibular schwannoma, benign
paroxysmal positional vertigo (BPPV), perilymphatic fistula, trauma, infection, and
autoimmune inner ear disease. A unilateral lesion in the vestibular system is thought to
cause the sensation of vertigo present in these peripheral disorders/diseases (Brandt and
Daroff, 1980). Central causes of vertigo are due to infarctions, demyelinating disease,
degenerative disease, or vascular disorders (Parker and Weiss, 1976; Wennmo and
Hindfelt, 1980). Specifically, central disorders known to cause vertigo include vascular
loops, vertebrobasilar insufficiency, multiple sclerosis, brainstem disease, migraine, and
cervical vertigo (Applebaum and Valvassori, 1984; Kayan and Hood, 1984; Grenman,
1988; Grad and Baloh, 1989).
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BPPV is the most common form of vertigo (Bath et al, 2000). BPPV is thought to
arise from interaction of the cupula of the affected semicircular canal and displaced
otoconia from the otolith organs. The otoconia, which are normally located in the utricle,
are dislocated. Subsequently, the otoconia become free floating and affected by gravity.
When the head is moved to a provoking position, these otoconia move into the canal and
displace the cupula, thus resulting in vertigo and nystagmus (Belafsky et al, 2000;
Marcias et al, 2000). Although all three semicircular canals may be affected, posterior
canal BPPV is the most common form due to its anatomical position (Herdman and Tusa,
1996).
BPPV was first described by Barany (1921). The classic indicators of this disease
include: vertigo and rotary nystagmus (eyes moving clockwise or counterclockwise)
towards the affected ear with a latency of several seconds. The nystagmus typically lasts
for less than one minute and is fatigable after multiple positioning techniques (Lanska
and Remler, 1997; Konrad et al, 1999; Belafsky et al, 2000).
These classic indicators are elicited by specific positioning techniques used in
standard vestibular assessment (Dix and Hallpike, 1952; Belafsky et al, 2000; Nunez et
al, 2000). These positioning techniques require the clinician to place the patient on
his/her back with hyperextension of the neck and the head turned to one side or the other.
A positive finding is indicated when this positioning provokes the rotary nystagmus and
vertigo already described.
Although the positioning techniques described above are able to definitively
diagnose BPPV, the test often considered the most useful in the diagnosis of peripheral
vestibular diseases, in general, is the bithermal caloric test. The caloric test, a component
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of videonystagmography (VNG) assessment, is used to stimulate the horizontal
semicircular canals so that the response of each ear can be compared. The patient lies
supine with the head elevated to 30°, aligning the horizontal semicircular canals in a
vertical position. Each ear is separately stimulated using a warm and cool stimulus. A
warm stimulus heats the endolymph in the test ear and causes a convection current that
flows upward and deflects the cupula toward the utricle. Movement of the cupula toward
the utricle results in an excitatory response. This excitation creates an asymmetry in
primary afferent firing between the inner ears and triggers nystagmus with the fast phase
beating in the direction of the stimulated ear and the slow phase toward the opposite
direction. Irrigating the ear with cool air or water will decrease the temperature of the
endolymph, causing it to flow downward and deflecting the cupula away from the utricle.
This results in an inhibitory response and causes the fast phase component of the
nystagmus to beat away from the stimulated ear. The slow-phase velocity of the
nystagmus is the value most commonly used for assessment of the caloric response
(Jacobson et al, 1997).
Caloric testing allows evaluation of the integrity of the right and left horizontal
semicircular canals, separately, and allows for comparison of the strength of the response
of each system. A difference of more than 20% between responses from the ears is
considered significant for a weak vestibular system (Jongkees et al, 1962). This finding
is called a unilateral weakness, implying a peripheral vestibular disorder on the side with
the diminished response (Jacobson et al, 1997). In a unilateral weakness, there is an
asymmetry in the magnitude of information entering the brainstem, thus generating
different nystagmus characteristics from each ear. In other words, the two ears are
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reacting differently (asymmetrically) to the same type of stimulation. Caloric testing
allows for diagnosis of asymmetric function or unilateral weakness in the peripheral
vestibular system (Jacobson et al, 1997), a peripheral vestibulopathy.
There are numerous disorders that may cause a unilateral peripheral
vestibulopathy and are reportedly associated with BPPV (Pollak et al, 2002). The
literature suggests that vestibular neuritis, labyrinthitis, or Meniere’s disease may be
existing inner ear disorders that later cause BPPV once the patient is out of the acute
phase (Hughes and Proctor, 1997; Bath et al, 2000). Gans (2000) reports that patients
with any of these underlying vestibular disorders would likely demonstrate a unilateral
weakness on the caloric subtest. Cerebrovascular disease including stroke/transient
ischemic attacks (TIAs), basilar artery insufficiency, vertebrobasilar insufficiency, or
migraine have also been reported to cause a unilateral weakness on caloric testing and
may precede BPPV (Katasarkas and Kirkham, 1978; Kurizky et al, 1981; Toglia et al,
1981; Baloh et al, 1987; Hughes and Proctor, 1997; Kumar et al, 1998; Pollak et al,
2002).
Head trauma has also been reported as precipitating the onset of BPPV, but has
not been reported to cause peripheral vestibulopathy (Karlberg et al, 2000). Disorders
affecting the peripheral vestibular system that may be present prior to BPPV without a
reported incidence of unilateral weakness are chronic ear infections and a history of ear
surgery (Hughes and Proctor, 1997; Karlberg et al, 2000; Pollak et al, 2002).
The incidence of peripheral vestibulopathy for BPPV patients has been reported
in the range of 3% to 50% (Hughes and Proctor, 1997; Gans, 2000; Karlberg et al, 2000;
Pollak et al, 2002). This broad range may reflect variability among the patients or in the

6

Allison Hulslander

methodology of the various studies. For example, patients with an underlying vestibular
disorder may be more likely to present with a unilateral weakness on the caloric subtest
than patients without an underlying vestibular disorder. Based on the published data, it is
clear that not all patients diagnosed with BPPV will have a peripheral vestibulopathy on
the affected side. However, for patients with BPPV and a unilateral weakness on the
caloric test, there is sufficient evidence to be concerned about a more serious underlying
inner ear disorder. This underlying vestibular disorder may cause imbalance and
instability for the patient. Therefore, the purpose of this study was to determine the
incidence of peripheral vestibulopathy in two groups of BPPV patients using data
collected during caloric testing on these patients. One group had a positive history of
prior otologic disease and the other group had a negative history of prior otologic disease.
It was hypothesized that a greater incidence of peripheral vestibulopathy would be
observed for the group with prior otologic disease and differences between the groups in
the current investigation may explain the variability among reports investigating the
incidence of peripheral vestibulopathy in patients with BPPV.
METHODS
Participants
A retrospective study of 157 patients assessed and treated between January, 1999
and August, 2002 at the American Institute of Balance (AIB) was conducted. The
patients selected for review in this study were seen for evaluation and treatment of
vertigo and were diagnosed with BPPV of the posterior canal. Any patient with a
negative finding on the modified Dix-Hallpike (Gans, 2002) was excluded from this
study. Those patients identified as having horizontal canal, anterior canal, or recurrent
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BPPV upon initial diagnosis or secondary to migration following initial treatment, were
excluded from the study. The patients meeting the inclusion criteria were divided into
two subject groups: 49 subjects aged 40 - 89 years (mean = 66) with a prior history of
otologic disease (PosHx) and 108 subjects aged 25 - 95 years (mean = 70.4) without a
prior history of otologic disease (NegHx). A t-test indicated no difference in age between
the two groups, t (48)= -1.83, p=0.70. There were 34 females (56%) in the PosHx group
and 78 females (62%) in the NegHx group.
Procedures
All patients received a complete assessment using the standard test protocol of
AIB. Results from this protocol were used to determine subject eligibility and
subsequent grouping. The three main factors considered included diagnosis of posterior
canal BPPV, otologic history, and caloric testing results.
A.I.B. Standard Test Protocol
Case history information regarding detailed presenting complaints, family history,
drug history, and associated symptoms (hearing loss, tinnitus, and aural pressure) was
obtained. History of prior otologic disease such as labyrinthitis, vestibular
neuritis/labyrinthine ischemia, and Meniere’s disease were recorded. Prior medical
history including cardiovascular findings, chronic intractable motion intolerance,
stroke/TIA, diabetes, migraine, and head trauma were also noted.
The otologic examination consisted of otoscopic inspection of the tympanic
membranes. A vertebral artery screening test and Babinsky reflexes were performed.
Balance was assessed by the Sensory Organization Performance test, including the
Romberg and Fukuda step test. Audiometry, immittance, and otoacoustic emissions

8

Allison Hulslander

results were obtained. If the patient was not previously referred for imaging studies, an
auditory brainstem response (ABR) was performed. Vestibular autorotation and a
complete VNG test battery including: ocular motor pursuit, gaze, high frequency headshake, air calorics, and positional tests were performed. All testing was performed in one
appointment.
Diagnosis of BPPV
Diagnosis of posterior canal BPPV was based on the presence of a positive
finding for the modified Dix-Hallpike test. Classic positive indicators include: 1)
transient rotary nystagmus toward the undermost ear; 2) subjective vertigo that parallels
the nystagmus; 3) latency of onset of nystagmus.
Otologic History
The PosHx group consisted of those patients reporting labyrinthitis, vestibular
neuritis/ labyrinthine ischemia, or Meniere’s disease on their case history form or during
their initial case history interview. Those reporting none of these disorders were placed
in the NegHx group. Patients placed in the NegHx group reporting head trauma,
cardiovascular disease, stroke/TIA, diabetes, migraine, and chronic intractable motion
intolerance on their case history forms, or during their initial history interview were
further categorized by these conditions.
Unilateral Weakness
The incidence of peripheral vestibulopathy in each of these groups was
determined using caloric testing results and the Jongkees et al. (1962) formula.
Unilateral weakness was defined as a difference in the mean slow phase velocity of 23%
or greater between ears. This is a stricter criterion than the 20% difference used in some
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labs, but is less strict than the criterion reported in other studies (Karlberg et al, 2000).
Subjects meeting the 23% or greater unilateral weakness were considered to have an
underlying vestibular disorder or peripheral vestibulopathy.
RESULTS
Each group was analyzed in terms of diagnostic factors associated with BPPV.
This information is shown for the PosHx group in Figure 1 and for the NegHx group in
Figure 2. As shown, the most common diagnostic category for the PosHx group was
vestibular neuritis/ labyrinthine ischemia. This was the factor for 37 of the subjects
(79.5%) in the PosHx group. For the subjects in the NegHx group, cardiovascular
disease was the most prominent associated factor (27.8%). The right ear was the ear with
BPPV in 32 (65%) of the subjects in the PosHx group and 57 (53%) of the subjects in the
NegHx group.
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Figure 1. Distribution of subjects by diagnostic category for the PosHx group.
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Diagnostic category
Figure 2. Distribution of subjects by diagnostic category for the NegHx group.
Results were averaged and examined for trends. As shown in Figure 3, the
incidence of peripheral vestibulopathy (unilateral weakness greater than 23%) was 53.1%
for the PosHx group and 30.6% for the NegHx. To determine if the incidence of
peripheral vestibulopathy for each group was different, the data were examined using a
chi-square (Χ2) analysis. Using this analysis, it was determined that the PosHx group had
a significantly higher incidence of peripheral vestibulopathy than the NegHx group (Χ2 =
7.28, p < 0.05). In addition, the number of patients with BPPV and peripheral
vestibulopathy in the same ear was 17 (65%) in the PosHx group and 17 (52%) in the
NegHx group.
Average unilateral weakness results were also determined. All values of
unilateral weakness, including those that did not meet the 23% criterion, were included in
this analysis. An independent t-test revealed a significant difference between the mean
unilateral weakness results for the two groups, t (48)= 2.14, p=0.03. This result indicated
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Figure 3. Incidence of peripheral vestibulopathy in the PosHx and NegHx groups. The
filled bar represents the percentage of subjects with peripheral vestibulopathy from the
NegHx group and the hashed bar represents the percentage of subjects with peripheral
vestibulopathy from the PosHx group.
that the PosHx group had a significantly larger average caloric weakness (25.8%)
compared to the NegHx group (17.8%).
As shown in Figure 4, a history of vestibular neuritis/labyrinthine ischemia
resulted in the greatest incidence of caloric weakness in the PosHx group with over half
(56.8%) of these subjects exhibiting peripheral vestibulopathy. Meniere’s disease (50%)
and labyrinthitis (42.9%) produced slightly lower incidences of caloric weakness in the
PosHx group.
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Figure 4. Incidence of peripheral vestibulopathy by diagnostic category in the PosHx
group.
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Figure 5. Incidence of peripheral vestibulopathy by diagnostic category in the NegHx
group.
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Subjects with diabetes and stroke/TIA yielded the greatest incidences of unilateral
weakness in the NegHx group with 46.2% and 40%, respectively. Subjects with migraine
exhibited an incidence of 35.3% and those with a history of head trauma demonstrated
the smallest incidence of caloric weakness (22.2%) in the NegHx group. This data is
shown in Figure 5.
DISCUSSION
Presently in the literature, the incidence of peripheral vestibulopathy in BPPV
patients ranges from 3 to 50% (Hughes and Proctor, 1997; Gans, 2000; Karlberg et al,
2000; Pollak et al, 2002). The purpose of this study was to attempt to explain the
variability among these studies by determining if there was a greater incidence of
unilateral weakness in BPPV patients with a positive history of otologic disease
compared to the incidence of unilateral weakness in BPPV patients without such a
history. Results indicated that BPPV patients with a prior history of ear disease not only
have a greater incidence of underlying peripheral vestibulopathy (53.1%) than those
without a history of an inner ear disorder (30.6%), but the BPPV patients with a positive
history of otologic disease also show a larger average unilateral weakness (25.8%) than
those BPPV patients without a prior otologic disorder (17.8%).
It is important to understand that a prerequisite for posterior canal BPPV is, at
least, partially intact functioning of the posterior semi-circular canal. Karlberg et al.
(2000) suggest that any inner ear disorder that causes displacement of otoconia without
complete impairment of posterior canal function could produce posterior canal BPPV.
Karlberg et al. also indicate that audiometry and caloric testing should be performed on
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all patients with BPPV in order to recognize any inner ear disorder that might be causing
the BPPV.
The present study found that a prior history of vestibular neuritis/labyrinthine
ischemia produced the greatest incidence of peripheral vestibulopathy (56.8%).
Approximately 43% of the patients reporting a history of labyrinthitis also had a
peripheral vestibulopathy. The literature confirms this relationship between BPPV and
acute unilateral peripheral vestibulopathy (i.e. vestibular neuritis/labyrinthine ischemia
and labyrinthitis) (Katsarkas and Kirkham, 1978; Baloh et al, 1987; Harada et al, 1993;
Karlberg et al, 2000). In these other reports, patients were considered to have an acute
unilateral peripheral vestibulopathy if they had a history of a single attack of sudden
spontaneous vertigo slowly decreasing over days, a unilateral weakness (>25% caloric
weakness), and no relevant auditory symptoms or findings. They stated that the finding
of posterior canal BPPV nystagmus is a sign of the functional integrity of the vestibuloocular reflex pathway from the posterior semi-circular canal (Harada et al, 1993).
Vestibular neuritis and labyrinthitis often affect the superior vestibular nerve and the
structures it innervates, including the cristae of the anterior and horizonal semi-circular
canals and the macula of the utricle. Vertigo and a unilateral weakness on caloric testing
are produced by an impairment of the horizontal canal. Damage to the utricle could also
lead to displacement of the otoconia and cause posterior canal BPPV (Karlberg et al,
2000).
Meniere’s disease has also been demonstrated to cause BPPV and peripheral
vestibulopathy (Stahle and Bergman, 1967; Thomas and Harrison, 1971; Hulshof and
Baarsma, 1981; Hughes and Proctor, 1997; Bath et al, 2000). In the current study
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Meniere’s disease was present in 2% of the patients. This finding is consistent with
earlier studies reporting that 1 - 2% of BPPV cases were associated with Meniere’s
disease (Karlberg et al, 2000). Fifty percent of these Meniere’s patients also had a
peripheral vestibulopathy. This is slightly lower than the 60 - 74% incidence of
peripheral vestibulopathy reported to occur with Meniere’s disease in the literature
(Stahle and Bedrgman, 1967; Thomas and Harrison, 1971; Hulshof and Baarsma, 1981).
This apparent discrepancy could be associated with the fact that the stage of the
Meniere’s disease, active or destructive, was not taken into account.
The pathophysiology underlying the relationship between Meniere’s disease and
BPPV is not yet completely known. It has been proposed that loose otoconia could cause
a decrease in endolymphatic absorption, resulting in Meniere’s disease secondary to
BPPV. But, it has also been proposed that endolymphatic hydrops might damage the
utricle, resulting in loose otoconia and BPPV secondary to Meniere’s disease. The latter
explanation is thought to be the most realistic (Karlberg et al, 2000).
The literature also supports the finding of cerebrovascular disease, including
stroke/ TIA and migraine, resulting in a peripheral vestibulopathy (Grad and Baloh, 1989;
Hughes and Proctor, 1997; Kumar et al, 1998; Pollak et al, 2002). Migraine and BPPV in
the same individual have also been frequently reported (Schiller and Herdberg, 1960;
Kayan and Hood, 1984). For patients with a history of migraine, it is thought that the
BPPV is caused by vascular labyrinthine injury associated with the migraine disorder
(Hughes and Proctor, 1997). The current study found a 35.3% incidence of peripheral
vestibulopathy in the patients reporting migraine during case history. This is in
agreement with reports in the literature suggesting 22 - 44% of patients with migraine
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will exhibit peripheral vestibulopathy (Kuritzky et al, 1981; Toglia et al, 1981).
Stroke/TIA have also been reported to produce peripheral vestibulopathy and precede
BPPV (Katsarkas and Kirkham, 1978; Baloh et al, 1987; Hughes and Proctor, 1997;
Kumar et al, 1998; Pollak et al, 2002). In the current study, forty percent of the BPPV
patients reporting a history of stroke/TIA also have a peripheral vestibulopathy. Grad
and Baloh (1989) reported that 42% of patients with cerebrovascular disease also had a
peripheral vestiulopathy. A history a stroke/TIA has also been reported to be a central
cause of dizziness (Bath et al, 2000).
In previous studies, a history of head trauma was present in 14 - 27% of patients
(Karlberg et al, 2000). The current study found a history of head trauma in 11% of the
subjects selected. Head trauma has been established to precede BPPV, but not to cause a
unilateral weakness (Karlberg et al, 2000). This study found 4 of the 18 (22.2%) patients
reporting head trauma also had a unilateral weakness on caloric testing.
Cardiovascular disease, such as postural hypotension or congestive heart failure,
has also been reported to cause dizziness (Oghalai et al, 2000). However, cardiovascular
disease has not been proven to cause a peripheral vestibulopathy or to precede BPPV. In
the current study, 27% of the BPPV patients reporting a history of cardiovascular disease
also had a peripheral vestibulopathy.
Diabetes mellitus was the diagnostic category producing the greatest incidence of
peripheral vestibulopathy (46.2%) in the NegHx group. Diabetes accelerates
athersclerosis, which may damage the labyrinthine, visual, and somatosensory function.
It also causes peripheral neuropathy and diabetic retinopathy (Konrad et al, 1999).
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Patients presenting with BPPV and an additional vestibulopathy may have a
higher incidence of ongoing symptoms following a particle repositioning maneuver than
those patients with pure BPPV (Pollak et al, 2002). This may suggest that a patient with
BPPV secondary to vestibular neuritis may be less likely to clear from a single treatment
versus an idiopathic occurrence of BPPV. This may be caused by an uncompensated
horizontal canal induced non-paroxysmal dizziness or by an unidentified vertical canal,
otolith, or central vestibular dysfunction leading to positional vertigo (Pollak et al, 2002).
It has also been demonstrated that patients with peripheral vestibulopathy have a
substantially better outcome than patients with central vestibular dysfunction (Pollak et
al, 2002).
In general, 90% of patients with dizziness can be diagnosed by history alone
(Bath et al, 2000). Obtaining a detailed patient history allows the clinician to determine
if the patient has had an otologic event, often in the absence of hearing loss. It also
allows the clinician to properly triage patients for vestibular rehabilitation therapy
including canalith repositioning maneuvers, adaptation exercises, balance re-training, and
fall prevention in the elderly population. This is extremely important since treatment for
BPPV, vestibulopathy, and disequilibrium has been shown to be highly efficacious when
properly administered (Gans and Harrington-Gans, 2002). Some individuals with BPPV
complain of reduced balance, ataxia, and/ or lightheadedness following the treatment of
the positional vertigo caused by BPPV (Konrad et al, 1999). An underlying vestibular
disorder may be the cause of balance problems in these patients (Nadol and Schuknecht,
1989). The findings of this study may prove to be clinically significant in the
management of these patients.
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SUMMARY AND CONCLUSIONS
The purpose of this experiment was to investigate the incidence of peripheral
vestibulopathy in BPPV patients with and without a prior history of otologic disease.
Data were collected for a group of patients with a positive history of otologic disease and
for a group of patients with a negative history of otologic disease. All patients included
in this study were diagnosed with posterior canal BPPV.
A greater incidence of peripheral vestibulopathy and a larger average unilateral
weakness was found for the patients with a positive otologic history than for the patients
with a negative otologic history. Specific conclusions were: 1) patients with posterior
canal BPPV and a positive otologic history are more likely to have a peripheral
vestibulopathy than patients with posterior canal BPPV and a negative otologic history,
2) incidence rates of peripheral vestibulopathy reported in the literature for posterior
canal BPPV are likely to be influenced by the relative numbers of subjects with and
without prior otologic history, 3) for this study, the most common diagnostic category for
the positive history group was vestibular neuritis/labyrinthine ischemia and this category
also presented with the highest incidence of peripheral vestibulopathy, 4) the most
common diagnostic category for the negative history group was cardiovascular disease
but the category that presented with the highest incidence of peripheral vestibulopathy for
this group was diabetes.
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